Latest market price
3.79
-0.26-6.42%
OverviewShort InterestFilings
VNDAQT35Vanda Pharmaceuticals Inc.·NASDAQ
3.79-6.42%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 202610-QQuarterly report
Oct 28, 20268-KCurrent report
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 09, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 19, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20263Initial statement of beneficial ownership
Jun 05, 20268-KCurrent report
Jun 05, 2026S-8Registration of employee benefit securities
May 20, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 05, 2026EFFECTNotice of effectiveness
Apr 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 24, 20264Statement of changes in beneficial ownership
#1 / 25 of 295
Page
▼
/ 12